malabaricone c has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, SK; Banerjee, D; Bauri, AK; Chattopadhyay, S; Guha, RK | 1 |
| Choe, J; Kang, J; Lee, JH; Min, BS; Tae, N | 1 |
2 other study(ies) available for malabaricone c and dinoprostone
| Article | Year |
|---|---|
Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; ErbB Receptors; Fruit; Gastric Mucins; Gastric Mucosa; Glycogen; Indomethacin; Lipid Peroxidation; Male; Membrane Proteins; Mice; Myristicaceae; Omeprazole; Oxidative Stress; Periodic Acid-Schiff Reaction; Plant Extracts; Protein Carbonylation; Resorcinols; Stomach; Stomach Ulcer; Time Factors; Wound Healing | 2008 |
Malabaricone C suppresses lipopolysaccharide-induced inflammatory responses via inhibiting ROS-mediated Akt/IKK/NF-κB signaling in murine macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; I-kappa B Kinase; Interferon-gamma; Interleukin-6; Lipopolysaccharides; Macrophages, Peritoneal; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resorcinols | 2012 |